Enhancing the Inhibition of Corneal Neovascularization Efficacy by Self-Assembled into Supramolecular Hydrogel of Anti-Angiogenic Peptide DOI Creative Commons
Guojuan Pu, Zhen Liang,

Jieran Shi

et al.

International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 7605 - 7616

Published: July 1, 2024

Corneal neovascularization (CNV) is a common eye disease that leads to blindness. New treatment strategies are urgently needed due the limitations of current methods.

Language: Английский

Deciphering the Power of Resveratrol in Mitophagy: From Molecular Mechanisms to Therapeutic Applications DOI Open Access
Hongmei Liu, Yixuan Song, Huan Wang

et al.

Phytotherapy Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 4, 2025

Resveratrol (RES), a natural polyphenolic compound, has garnered significant attention for its therapeutic potential in various pathological conditions. This review explores how RES modulates mitophagy-the selective autophagic degradation of mitochondria essential maintaining cellular homeostasis. promotes the initiation and execution mitophagy by enhancing PINK1/Parkin-mediated mitochondrial clearance, reducing reactive oxygen species production, mitigating apoptosis, thereby preserving integrity. Additionally, regulates through activation key molecular targets such as AMP-activated protein kinase (AMPK), mechanistic target rapamycin (mTOR), deacetylases (SIRT1 SIRT3), quality control (MQC) pathways, demonstrating substantial effects multiple disease models. We provide detailed account biosynthetic pharmacokinetics, metabolic characteristics RES, focusing on role modulation implications medical applications. Potential adverse associated with clinical use are also discussed. Despite promising properties, application is limited issues bioavailability pharmacokinetic profiles. Future research should concentrate developing derivatives that precisely modulate mitophagy, unlocking new avenues therapy.

Language: Английский

Citations

4

Bioorthogonal In Situ Polymerization of Dendritic Agents for Hijacking Lysosomes and Enhancing Antigen Presentation in Cancer Cells DOI
Dan Zhong,

Xingyu Hou,

Dayi Pan

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(26)

Published: March 16, 2024

A low-generation lysine dendrimer, SPr-G2, responds to intracellular glutathione initiate bioorthogonal in situ polymerization, resulting the formation of large assemblies mouse breast cancer cells. The SPr-G2 can interact with lysosomes induce lysosome expansion and enhance lysosomal membrane permeabilization, leading major histocompatibility complex class I upregulation on tumor cell surfaces ultimately death. Moreover, use dendrimer conjugate chemotherapeutic drug, camptothecin (CPT), boost therapeutic potency CPT. Excellent antitumor effects vitro vivo are obtained from combinational treatment This effect also enhances immunity through promoting activation cytotoxic T cells tissues maturation dendritic study shed new light development peptide agents for therapy.

Language: Английский

Citations

8

Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment DOI Creative Commons

Xiuying Duan,

Yi‐Lei Zhao,

Houyang Hu

et al.

Biomaterials Research, Journal Year: 2024, Volume and Issue: 28

Published: Jan. 1, 2024

The reprogramming of tumor metabolism presents a substantial challenge for effective immunotherapy, playing crucial role in developing an immunosuppressive microenvironment. In particular, the degradation amino acid L-tryptophan (Trp) to kynurenine (Kyn) by indoleamine-pyrrole 2,3-dioxygenase 1 (IDO1) is one most clinically validated pathways immune suppression. Thus, regulating Trp/Kyn IDO1 inhibition represents promising strategy enhancing immunotherapy. Herein, metabolism-regulated nanoparticles are prepared through metal coordination-driven assembly inhibitor (NLG919) and stimulator interferon genes (STING) agonist (MSA-2) enhanced After intravenous administration, assembled could efficiently accumulate tumors, bioavailability NLG919 down-regulating Trp Kyn remodel Meanwhile, released MSA-2 evoked potent STING pathway activation triggering response. antitumor immunity induced significantly inhibited development primary metastatic as well B16 melanoma. Overall, this study provided novel paradigm immunotherapy synergistic activation.

Language: Английский

Citations

8

“Mix‐and‐Match”: Self‐Sorting Assembly Governed Supramolecular Polymeric Nanomedicine for Boosting Combined Chemo/Phototherapy DOI

Yanggui Wu,

Ting Li,

Zeke Li

et al.

Advanced Materials, Journal Year: 2025, Volume and Issue: unknown

Published: April 7, 2025

Abstract Precise cancer nanomedicine requires rational molecular instructions of therapeutic agents. Harnessing the structure‐property‐function relationships represents a practical strategy toward smart and effective nanomedicine. A structurally novel hydrogen‐bonded (H‐bonded) supramolecular nanoformulation generated by orthogonal self‐sorting assembly chemo‐prodrug (FPtF) phototherapeutics (BPeB) is here reported, to reach an autonomous with improved anti‐tumor efficacy combining chemo/phototherapy (CT/PT). The high‐fidelity H‐bonding modularity from privileged heterocomplementary diaminopyridine/5‐fluorouracil (DAP/FU) Hamilton wedge/barbiturate (HW/Ba) pairs, respectively enable precise spatial control binding interactions FPtF BPeB, in turn allowing process specific “mix‐and‐match” capability. To directly stimulate phototherapy BPeB via near‐infrared (NIR) light, spectral matched upconversion nanoparticles (UCNPs, β‐NaYF 4 :Yb,Er) are encapsulated simultaneously. As result, polymeric nanomicelles, i.e., F/B/U@PHDO, readily fabricated. Moreover, distinct association constant (Ka) DAP/FU (≈10 2 M −1 ) HW/Ba 4‐5 pairs reflect different strengths stabilities H‐bonds, thus endowing programmable dissociation, accompanied release through pH/thermal‐stimuli. Therapeutic regime appreciated outcomes ultimately accomplished combined CT/PT. opportunities offered design anticipated point new paradigm for therapy.

Language: Английский

Citations

1

Applications of self-assembled peptide hydrogels in anti-tumor therapy DOI Creative Commons

Yue Hua,

Yang Shen

Nanoscale Advances, Journal Year: 2024, Volume and Issue: 6(12), P. 2993 - 3008

Published: Jan. 1, 2024

Peptides are a class of active substances composed variety amino acids with special physiological functions.

Language: Английский

Citations

5

Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer DOI
Wenjuan Li, Shanhe Li,

Minghui Zhu

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(19), P. 17243 - 17258

Published: Sept. 19, 2024

To effectively inhibit the growth and metastasis of non-small cell lung cancer (NSCLC) overcome its multidrug resistance (MDR), we designed synthesized a series rhodium (Rh, III) 2-benzoylpyridine thiosemicarbazone complexes. Through studying their structure-activity relationships, identified Rh(III) complex (Rh4) with excellent cytotoxicity against multidrug-resistant cells (A549/ADR cells). Additionally, successfully constructed an apoferritin (AFt) nanoparticle (NP) delivery system (AFt-Rh4 NPs). Importantly, AFt-Rh4 NPs not only exhibited antitumor antimetastatic capabilities NSCLC

Language: Английский

Citations

5

A Dual‐Channel Ca2+ Nanomodulator Induces Intracellular Ca2+ Disorders via Endogenous Ca2+ Redistribution for Tumor Radiosensitization DOI
Dianyu Wang,

Haixue Jia,

Hongmei Cao

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(29)

Published: May 1, 2024

Tumor cells harness Ca

Language: Английский

Citations

4

Redox-responsive self-assembled peptide hydrogel for mitochondrial-targeted anticancer drug delivery DOI
Leixia Mei,

Qing Mei,

Weimiao Dong

et al.

Applied Materials Today, Journal Year: 2024, Volume and Issue: 41, P. 102471 - 102471

Published: Oct. 13, 2024

Language: Английский

Citations

4

A Novel Prognostic Signature of Mitophagy-Related E3 Ubiquitin Ligases in Breast Cancer DOI Open Access

Kangjing Bian,

Chihyu Yang, Feng Zhang

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(4), P. 1551 - 1551

Published: Feb. 12, 2025

Mitophagy plays a critical role in maintaining mitochondrial quality and cellular homeostasis. But the specific contribution of mitophagy-related E3 ubiquitin ligases to prognoses remains largely unexplored. In this study, we identified novel ligase prognostic signature using least absolute shrinkage selector operator (LASSO) multivariate Cox regression analyses breast cancer. Based on median risk scores, patients were divided into high-risk low-risk groups. Functional enrichment conducted explore biological differences between two Immune infiltration, drug sensitivity, mitochondrial-related phenotypes also analyzed evaluate clinical implications model. A four-gene (ARIH1, SIAH2, UBR5, WWP2) was identified, Kaplan-Meier analysis demonstrated that group had significantly worse overall survival (OS). The exhibited disrupted metabolism immune dysregulation with upregulated checkpoint molecules. Additionally, higher sensitivity several drugs targeting Akt/PI3K/mTORC1 signaling axis. Accompanying metabolic dysregulation, mtDNA stress elevated, contributing activation senescence-associated secretory phenotype (SASP) group. conclusion, provides robust tool for stratification offers insights interplay mitophagy, modulation, therapeutic responses

Language: Английский

Citations

0

Near-infrared light-triggered in situ self-assembly nanomedicine for treating antibiotic-resistant bacterial infection DOI
Yu Zhang,

Chunhua Ren,

Huayang Liu

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 161303 - 161303

Published: March 1, 2025

Language: Английский

Citations

0